NYSE:EW - Edwards Lifesciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$135.95 -1.62 (-1.18 %)
(As of 05/27/2018 03:23 AM ET)
Previous Close$135.95
Today's Range$135.25 - $137.82
52-Week Range$100.20 - $143.22
Volume1.00 million shs
Average Volume1.19 million shs
Market Capitalization$29.00 billion
P/E Ratio35.78
Dividend YieldN/A
Beta0.64

About Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences logoEdwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and related delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings and the beating-heart mitral repair systems; and cardiac cannula devices, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; Oximetry Central Venous catheters, as well as clinical monitoring platforms that display a patient's physiological status; and disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

Receive EW News and Ratings via Email

Sign-up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:EW
CUSIP28176E10
Phone949-250-2500

Debt

Debt-to-Equity Ratio0.14
Current Ratio2.07
Quick Ratio1.63

Price-To-Earnings

Trailing P/E Ratio35.78
Forward P/E Ratio29.36
P/E Growth2.02

Sales & Book Value

Annual Sales$3.44 billion
Price / Sales8.34
Cash Flow$4.2103 per share
Price / Cash32.29
Book Value$15.40 per share
Price / Book8.83

Profitability

EPS (Most Recent Fiscal Year)$3.80
Net Income$583.60 million
Net Margins17.36%
Return on Equity28.60%
Return on Assets15.89%

Miscellaneous

Employees12,200
Outstanding Shares210,780,000

Edwards Lifesciences (NYSE:EW) Frequently Asked Questions

What is Edwards Lifesciences' stock symbol?

Edwards Lifesciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences' stock split? How did Edwards Lifesciences' stock split work?

Edwards Lifesciences's stock split before market open on Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly issued shares were distributed to shareholders after the market closes on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences stock prior to the split would have 200 shares after the split.

How will Edwards Lifesciences' stock buyback program work?

Edwards Lifesciences declared that its Board of Directors has initiated a share buyback program on Thursday, December 7th 2017, which authorizes the company to buyback $1,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued.

How were Edwards Lifesciences' earnings last quarter?

Edwards Lifesciences (NYSE:EW) released its quarterly earnings data on Tuesday, April, 24th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.11. The medical research company earned $938 million during the quarter, compared to analysts' expectations of $936.69 million. Edwards Lifesciences had a return on equity of 28.60% and a net margin of 17.36%. The firm's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.94 earnings per share. View Edwards Lifesciences' Earnings History.

When is Edwards Lifesciences' next earnings date?

Edwards Lifesciences is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Edwards Lifesciences.

What guidance has Edwards Lifesciences issued on next quarter's earnings?

Edwards Lifesciences issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share guidance of $4.50-$4.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.53. The company issued revenue guidance of $3.5-$3.9 billion, compared to the consensus revenue estimate of $3.85 billion.Edwards Lifesciences also updated its Q2 guidance to $1.05-$1.15 EPS.

What price target have analysts set for EW?

17 brokers have issued 12-month price objectives for Edwards Lifesciences' stock. Their forecasts range from $115.00 to $180.00. On average, they expect Edwards Lifesciences' stock price to reach $149.1429 in the next year. View Analyst Ratings for Edwards Lifesciences.

Are investors shorting Edwards Lifesciences?

Edwards Lifesciences saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 5,610,181 shares, an increase of 62.3% from the April 30th total of 3,456,057 shares. Based on an average daily trading volume, of 1,266,171 shares, the short-interest ratio is presently 4.4 days. Currently, 2.7% of the shares of the stock are short sold.

Who are some of Edwards Lifesciences' key competitors?

Who are Edwards Lifesciences' key executives?

Edwards Lifesciences' management team includes the folowing people:
  • Mr. Michael A. Mussallem, Chairman & CEO (Age 65)
  • Mr. Scott B. Ullem, Corp. VP & CFO (Age 51)
  • Mr. Donald E. Bobo Jr., Corp. VP of Strategy & Corp. Devel. (Age 56)
  • Mr. Larry L. Wood, Corp. VP of Transcatheter Heart Valve (Age 52)
  • Ms. Catherine M. Szyman, Corp. VP of Critical Care (Age 51)

Has Edwards Lifesciences been receiving favorable news coverage?

News articles about EW stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Edwards Lifesciences earned a media sentiment score of 0.12 on Accern's scale. They also assigned news articles about the medical research company an impact score of 45.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Edwards Lifesciences' major shareholders?

Edwards Lifesciences' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.43%), American Century Companies Inc. (1.32%), Northern Trust Corp (1.13%), Wells Fargo & Company MN (1.06%), Disciplined Growth Investors Inc. MN (0.98%) and Massachusetts Financial Services Co. MA (0.97%). Company insiders that own Edwards Lifesciences stock include Bernard J Zovighian, Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Dylan Sidoo, Huimin Wang, Jean-Luc M Lemercier, John T Cardis, Kieran Gallahue, Larry L Wood, Michael A Mussallem, Patrick B Verguet, Robert WA Sellers, Schack Wesley W Von, Scott B Ullem and William J Phd Link. View Institutional Ownership Trends for Edwards Lifesciences.

Which major investors are selling Edwards Lifesciences stock?

EW stock was sold by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., WCM Investment Management CA, Sei Investments Co., Blair William & Co. IL, DekaBank Deutsche Girozentrale, Envestnet Asset Management Inc., Schroder Investment Management Group and Swiss National Bank. Company insiders that have sold Edwards Lifesciences company stock in the last year include Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Huimin Wang, Jean-Luc M Lemercier, Larry L Wood, Michael A Mussallem, Patrick B Verguet, Robert WA Sellers, Schack Wesley W Von, Scott B Ullem and William J Phd Link. View Insider Buying and Selling for Edwards Lifesciences.

Which major investors are buying Edwards Lifesciences stock?

EW stock was bought by a variety of institutional investors in the last quarter, including American Century Companies Inc., BlackRock Inc., OppenheimerFunds Inc., Rockefeller Capital Management L.P., Royal Bank of Canada, Chicago Capital LLC, Prudential Financial Inc. and Country Trust Bank. Company insiders that have bought Edwards Lifesciences stock in the last two years include Catherine M Szyman, Dylan Sidoo and Kieran Gallahue. View Insider Buying and Selling for Edwards Lifesciences.

How do I buy shares of Edwards Lifesciences?

Shares of EW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edwards Lifesciences' stock price today?

One share of EW stock can currently be purchased for approximately $135.95.

How big of a company is Edwards Lifesciences?

Edwards Lifesciences has a market capitalization of $29.00 billion and generates $3.44 billion in revenue each year. The medical research company earns $583.60 million in net income (profit) each year or $3.80 on an earnings per share basis. Edwards Lifesciences employs 12,200 workers across the globe.

How can I contact Edwards Lifesciences?

Edwards Lifesciences' mailing address is ONE EDWARDS WAY, IRVINE CA, 92614. The medical research company can be reached via phone at 949-250-2500 or via email at [email protected]


MarketBeat Community Rating for Edwards Lifesciences (EW)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  869 (Vote Outperform)
Underperform Votes:  635 (Vote Underperform)
Total Votes:  1,504
MarketBeat's community ratings are surveys of what our community members think about Edwards Lifesciences and other stocks. Vote "Outperform" if you believe EW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EW will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Edwards Lifesciences (NYSE:EW) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Edwards Lifesciences in the last 12 months. Their average twelve-month price target is $149.1429, suggesting that the stock has a possible upside of 9.70%. The high price target for EW is $180.00 and the low price target for EW is $115.00. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.822.892.942.81
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $149.1429$148.0667$141.9375$124.9474
Price Target Upside: 9.70% upside14.17% upside7.39% upside20.92% upside

Edwards Lifesciences (NYSE:EW) Consensus Price Target History

Price Target History for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE:EW) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/23/2018Royal Bank of CanadaBoost Price TargetOutperform$145.00HighView Rating Details
4/25/2018Northland SecuritiesDowngradeOutperform ➝ Market PerformHighView Rating Details
4/10/2018SunTrust BanksReiterated RatingBuy$180.00MediumView Rating Details
3/20/2018CowenReiterated RatingBuy$165.00LowView Rating Details
2/2/2018GuggenheimReiterated RatingBuy$162.00LowView Rating Details
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$135.00 ➝ $140.00HighView Rating Details
2/2/2018Stifel NicolausReiterated RatingBuy$155.00HighView Rating Details
2/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$135.00 ➝ $155.00HighView Rating Details
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $138.00HighView Rating Details
2/2/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$140.00 ➝ $174.00HighView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$140.00HighView Rating Details
1/2/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralMediumView Rating Details
12/8/2017BMO Capital MarketsReiterated RatingBuy$137.00LowView Rating Details
10/26/2017Deutsche BankLower Price TargetHold$122.00 ➝ $115.00N/AView Rating Details
8/28/2017William BlairReiterated RatingOutperform ➝ OutperformLowView Rating Details
7/27/2017Bank of AmericaBoost Price TargetPositive ➝ Buy$140.00 ➝ $150.00HighView Rating Details
7/27/2017Jefferies GroupBoost Price TargetBuy$115.00 ➝ $132.00HighView Rating Details
5/16/2017Goldman Sachs GroupInitiated CoverageConviction-Buy$138.00LowView Rating Details
2/8/2017Credit Suisse GroupSet Price TargetBuy$120.00N/AView Rating Details
2/2/2017Leerink SwannDowngradeOutperform ➝ Market PerformN/AView Rating Details
2/2/2017BTIG ResearchDowngradeBuy ➝ NeutralN/AView Rating Details
9/11/2016Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
8/22/2016UBSReiterated RatingBuyN/AView Rating Details
7/27/2016CitigroupBoost Price TargetSell$86.00 ➝ $94.00N/AView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$123.00N/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Edwards Lifesciences (NYSE:EW) Earnings History and Estimates Chart

Earnings by Quarter for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE:EW) Earnings Estimates

2018 EPS Consensus Estimate: $4.47
2019 EPS Consensus Estimate: $5.14
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$0.98$1.12$1.08
Q2 20184$1.11$1.16$1.14
Q3 20184$1.04$1.07$1.06
Q4 20184$1.17$1.21$1.20
Q1 20193$1.23$1.31$1.28
Q2 20193$1.25$1.34$1.30
Q3 20193$1.21$1.22$1.22
Q4 20193$1.31$1.40$1.35

Edwards Lifesciences (NYSE EW) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2018$1.14N/AView Earnings Details
4/24/2018Q1 2018$1.11$1.22$936.69 million$938.00 millionViewN/AView Earnings Details
2/1/2018Q4 2017$0.91$0.94$868.45 million$888.50 millionViewListenView Earnings Details
10/24/2017Q3 2017$0.86$0.84$833.85 million$821.50 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.88$1.08$839.16 million$842.00 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.82$0.94$776.51 million$883.50 millionViewN/AView Earnings Details
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
4/24/2012Q1 2012$0.24$0.27ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
10/25/2010Q3 2010$0.21$0.21ViewN/AView Earnings Details
7/21/2010Q2 2010$0.22$0.23ViewN/AView Earnings Details
4/20/2010Q1 2010$0.20$0.20ViewN/AView Earnings Details
2/4/2010Q4 2009$0.21$0.21ViewN/AView Earnings Details
10/21/2009Q3 2009$0.18$0.18ViewN/AView Earnings Details
7/20/2009Q2 2009$0.19$0.20ViewN/AView Earnings Details
4/27/2009Q1 2009$0.17$0.18ViewN/AView Earnings Details
2/3/2009Q4 2008$0.19$0.19ViewN/AView Earnings Details
10/21/2008Q3 2008$0.14$0.14ViewN/AView Earnings Details
7/22/2008Q2 2008$0.16$0.16ViewN/AView Earnings Details
4/22/2008Q1 2008$0.12$0.14ViewN/AView Earnings Details
2/5/2008Q4 2007$0.13$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Edwards Lifesciences (NYSE:EW) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Edwards Lifesciences (NYSE EW) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.84%
Institutional Ownership Percentage: 81.03%
Insider Trading History for Edwards Lifesciences (NYSE:EW)
Institutional Ownership by Quarter for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE EW) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2018Catherine M SzymanVPSell9,815$139.39$1,368,112.8520,012View SEC Filing  
5/17/2018Michael A MussallemCEOSell32,900$135.88$4,470,452.00112,731View SEC Filing  
5/15/2018Larry L. WoodVPSell6,300$137.26$864,738.00View SEC Filing  
5/9/2018Jean-Luc M LemercierVPSell5,634$134.91$760,082.9438,784View SEC Filing  
5/9/2018Scott B UllemCFOSell25,000$134.73$3,368,250.0035,968View SEC Filing  
5/7/2018Michael A MussallemCEOSell32,800$136.37$4,472,936.0061,131View SEC Filing  
5/4/2018Huimin WangVPSell3,800$131.93$501,334.0085,016View SEC Filing  
4/30/2018Michael A MussallemCEOSell32,800$128.46$4,213,488.0074,131View SEC Filing  
4/16/2018Larry L. WoodVPSell6,300$138.97$875,511.00View SEC Filing  
4/11/2018Jean-Luc M. LemercierVPSell5,633$139.42$785,352.86View SEC Filing  
4/4/2018Donald E. Bobo, Jr.VPSell4,000$134.78$539,120.00View SEC Filing  
4/4/2018Scott B UllemCFOSell25,000$137.17$3,429,250.0035,968View SEC Filing  
3/29/2018Donald E Bobo JrVPSell5,300$138.58$734,474.0024,908View SEC Filing  
3/28/2018Scott B UllemCFOSell25,000$137.33$3,433,250.0035,968View SEC Filing  
3/21/2018Michael A MussallemCEOSell32,800$139.74$4,583,472.0074,131View SEC Filing  
3/19/2018Huimin WangVPSell3,800$141.84$538,992.00View SEC Filing  
3/15/2018Larry L WoodVPSell6,300$141.49$891,387.00116,148View SEC Filing  
3/7/2018Jean-Luc M LemercierVPSell5,633$136.29$767,721.5744,298View SEC Filing  
2/20/2018Donald E Bobo JrVPSell5,300$134.70$713,910.0024,908View SEC Filing  
2/16/2018Larry L WoodVPSell6,300$134.27$845,901.00116,148View SEC Filing  
2/13/2018Michael A MussallemCEOSell32,800$126.69$4,155,432.0074,131View SEC Filing  
2/12/2018Donald E Bobo JrVPSell3,750$127.54$478,275.0019,608View SEC Filing  
2/9/2018William J Phd LinkDirectorSell12,000$122.24$1,466,880.0024,596View SEC Filing  
2/5/2018Robert W.A. SellersVPSell12,020$131.03$1,574,980.60View SEC Filing  
1/29/2018Donald E Bobo JrVPSell5,300$127.24$674,372.0024,908View SEC Filing  
1/16/2018Larry L WoodVPSell6,300$121.00$762,300.00116,148View SEC Filing  
1/4/2018Michael A. MussallemCEOSell32,800$114.97$3,771,016.00View SEC Filing  
12/28/2017Donald E. Bobo, Jr.VPSell5,300$114.08$604,624.00View SEC Filing  
12/28/2017Donald E. Bobo, Jr.VPSell5,300$114.08$604,624.00View SEC Filing  
12/19/2017Michael A. MussallemCEOSell32,800$114.82$3,766,096.00View SEC Filing  
12/15/2017Larry L. WoodVPSell18,960$114.58$2,172,436.80View SEC Filing  
11/29/2017Donald E. Bobo, Jr.VPSell5,300$116.45$617,185.00View SEC Filing  
11/20/2017Michael A. MussallemCEOSell32,900$106.86$3,515,694.00View SEC Filing  
11/15/2017Larry L. WoodVPSell18,960$104.76$1,986,249.60View SEC Filing  
11/9/2017Schack Wesley W VonDirectorSell1,000$104.15$104,150.002,622View SEC Filing  
10/30/2017Donald E. Bobo, Jr.VPSell5,300$101.12$535,936.00View SEC Filing  
10/30/2017Michael A. MussallemCEOSell32,900$100.93$3,320,597.00View SEC Filing  
10/16/2017Larry L WoodVPSell18,960$108.54$2,057,918.40View SEC Filing  
9/29/2017Donald E. Bobo, Jr.VPSell5,300$108.86$576,958.00View SEC Filing  
9/15/2017Larry L. WoodVPSell18,960$112.58$2,134,516.80View SEC Filing  
9/7/2017Michael A. MussallemCEOSell32,900$112.45$3,699,605.00View SEC Filing  
8/30/2017Larry L. WoodVPSell18,960$111.81$2,119,917.60View SEC Filing  
8/29/2017Donald E. Bobo, Jr.VPSell5,300$112.15$594,395.00View SEC Filing  
8/9/2017Michael A. MussallemCEOSell32,900$115.99$3,816,071.00View SEC Filing  
8/4/2017Donald E. Bobo, Jr.VPSell25,000$116.00$2,900,000.00View SEC Filing  
7/31/2017Catherine M. SzymanVPSell4,681$115.78$541,966.18View SEC Filing  
7/31/2017Michael A. MussallemCEOSell32,900$114.80$3,776,920.00View SEC Filing  
7/28/2017Donald E. Bobo, Jr.VPSell5,300$114.68$607,804.00View SEC Filing  
6/29/2017Donald E. Bobo, Jr.VPSell5,600$117.15$656,040.00View SEC Filing  
6/7/2017Michael A. MussallemCEOSell32,900$118.05$3,883,845.00View SEC Filing  
5/31/2017Patrick B. VerguetVPSell10,000$114.88$1,148,800.00View SEC Filing  
5/19/2017Dylan SidooDirectorBuy25,000$0.11$2,750.00
5/19/2017Patrick B. VerguetVPSell22,631$113.16$2,560,923.96View SEC Filing  
5/15/2017Patrick B. VerguetVPSell11,500$111.64$1,283,860.00View SEC Filing  
5/8/2017Donald E. Bobo, Jr.VPSell19,100$110.34$2,107,494.00View SEC Filing  
5/4/2017Donald E. Bobo, Jr.VPSell34,120$109.98$3,752,517.60View SEC Filing  
5/3/2017Michael A. MussallemCEOSell49,100$109.71$5,386,761.00View SEC Filing  
4/28/2017Michael A. MussallemCEOSell49,100$109.78$5,390,198.00View SEC Filing  
4/27/2017Bernard J. ZovighianVPSell18,050$109.21$1,971,240.50View SEC Filing  
4/5/2017Donald E. Bobo, Jr.VPSell13,720$93.58$1,283,917.60View SEC Filing  
3/30/2017Patrick B. VerguetVPSell24,000$93.90$2,253,600.00View SEC Filing  
3/6/2017Donald E. Bobo, Jr.VPSell13,720$90.01$1,234,937.20View SEC Filing  
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.002,524View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00127,341View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.0089,272View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66115,083View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.0062,796View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.001,941View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00129,944View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00129,944View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00129,944View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.0081,480View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.0068,256View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00115,107View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.0079,256View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.5081,480View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.0080,650View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.5081,299View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.0099,803View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.0067,649View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.0021,650View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.0021,650View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.0099,803View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.8033,824View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.0049,901View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.0013,158View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.0049,901View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.2034,174View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.2449,901View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.0049,901View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.0040,325View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.0034,174View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.0053,901View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.6043,838View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.0010,825View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.8034,174View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.0043,838View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00279,887View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.1150$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.1750$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.1350$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.1450$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.0020,604View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00263,850View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.0031,549View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.6977,199View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.0020,570View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00263,850View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.8077,199View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00263,850View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.0031,337View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.0048,681View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.5031,337View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00263,850View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00263,850View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.5031,337View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00263,850View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.0031,337View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00263,850View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.0031,337View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.0048,681View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Edwards Lifesciences (NYSE EW) News Headlines

Source:
DateHeadline
Form 4 Edwards Lifesciences For: May 23 Filed by: BOBO DONALD E JRForm 4 Edwards Lifesciences For: May 23 Filed by: BOBO DONALD E JR
www.streetinsider.com - May 26 at 4:36 PM
Insider Selling: Edwards Lifesciences (EW) VP Sells 9,815 Shares of StockInsider Selling: Edwards Lifesciences (EW) VP Sells 9,815 Shares of Stock
www.americanbankingnews.com - May 24 at 10:10 PM
Why Is Edwards Lifesciences (EW) Up 1.5% Since Its Last Earnings Report?Why Is Edwards Lifesciences (EW) Up 1.5% Since Its Last Earnings Report?
www.zacks.com - May 24 at 4:37 PM
BRIEF-Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards Sapien 3 ValveBRIEF-Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards Sapien 3 Valve
www.reuters.com - May 24 at 9:35 AM
Form 4 Edwards Lifesciences For: May 18 Filed by: GALLAHUE KIERANForm 4 Edwards Lifesciences For: May 18 Filed by: GALLAHUE KIERAN
www.streetinsider.com - May 24 at 9:35 AM
Form 4 Edwards Lifesciences For: May 18 Filed by: VON SCHACK WESLEY WForm 4 Edwards Lifesciences For: May 18 Filed by: VON SCHACK WESLEY W
www.streetinsider.com - May 24 at 9:35 AM
Edwards Lifesciences (EW) PT Raised to $145 at RBC Capital; Reinforced Confidence Following Management MeetingsEdwards Lifesciences (EW) PT Raised to $145 at RBC Capital; Reinforced Confidence Following Management Meetings
www.streetinsider.com - May 24 at 9:35 AM
Edwards Lifesciences To Present At The Bernstein 34th Annual Strategic Decisions ConferenceEdwards Lifesciences To Present At The Bernstein 34th Annual Strategic Decisions Conference
finance.yahoo.com - May 24 at 9:35 AM
Royal Bank of Canada Raises Edwards Lifesciences (EW) Price Target to $145.00Royal Bank of Canada Raises Edwards Lifesciences (EW) Price Target to $145.00
www.americanbankingnews.com - May 23 at 1:00 PM
Edwards Lifesciences (EW) Says Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With its SAPIEN 3 ValveEdwards Lifesciences (EW) Says Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With its SAPIEN 3 Valve
www.streetinsider.com - May 22 at 4:33 PM
Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 ValveReal-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve
finance.yahoo.com - May 22 at 9:08 AM
Edwards Lifesciences (EW) CEO Michael A. Mussallem Sells 32,900 SharesEdwards Lifesciences (EW) CEO Michael A. Mussallem Sells 32,900 Shares
www.americanbankingnews.com - May 21 at 10:10 PM
[$$] The AI Doctor Will See You Now[$$] The AI Doctor Will See You Now
finance.yahoo.com - May 21 at 9:27 AM
Contrasting ReWalk Robotics (RWLK) and Edwards Lifesciences (EW)Contrasting ReWalk Robotics (RWLK) and Edwards Lifesciences (EW)
www.americanbankingnews.com - May 19 at 1:29 PM
Edwards Lifesciences (EW) Enters $400M Accelerated Share Repurchase PlanEdwards Lifesciences (EW) Enters $400M Accelerated Share Repurchase Plan
www.streetinsider.com - May 18 at 10:39 AM
Insider Selling: Edwards Lifesciences (EW) VP Sells 6,300 Shares of StockInsider Selling: Edwards Lifesciences (EW) VP Sells 6,300 Shares of Stock
www.americanbankingnews.com - May 16 at 10:15 PM
$965.74 Million in Sales Expected for Edwards Lifesciences (EW) This Quarter$965.74 Million in Sales Expected for Edwards Lifesciences (EW) This Quarter
www.americanbankingnews.com - May 15 at 3:08 AM
Edwards Lifesciences To Webcast Annual Meeting Of StockholdersEdwards Lifesciences To Webcast Annual Meeting Of Stockholders
finance.yahoo.com - May 14 at 10:49 AM
Head-To-Head Contrast: Edwards Lifesciences (EW) & Wright Medical Group (WMGI)Head-To-Head Contrast: Edwards Lifesciences (EW) & Wright Medical Group (WMGI)
www.americanbankingnews.com - May 14 at 1:19 AM
 Brokerages Anticipate Edwards Lifesciences (EW) to Announce $1.12 Earnings Per Share Brokerages Anticipate Edwards Lifesciences (EW) to Announce $1.12 Earnings Per Share
www.americanbankingnews.com - May 13 at 11:18 AM
Edwards Lifesciences: Treating The #1 Killer In AmericaEdwards Lifesciences: Treating The #1 Killer In America
seekingalpha.com - May 12 at 9:54 AM
Insider Selling: Edwards Lifesciences (EW) CFO Sells 25,000 Shares of StockInsider Selling: Edwards Lifesciences (EW) CFO Sells 25,000 Shares of Stock
www.americanbankingnews.com - May 11 at 7:25 PM
Jean-Luc M. Lemercier Sells 5,634 Shares of Edwards Lifesciences (EW) StockJean-Luc M. Lemercier Sells 5,634 Shares of Edwards Lifesciences (EW) Stock
www.americanbankingnews.com - May 10 at 7:35 PM
Edwards Lifesciences (EW) Given Average Rating of "Buy" by BrokeragesEdwards Lifesciences (EW) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 10 at 5:25 PM
See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
finance.yahoo.com - May 9 at 9:25 AM
Free Post Earnings Research Report: Edwards Lifesciences’ Adjusted Sales Grew 9.3%; Adjusted EPS Surged 30%Free Post Earnings Research Report: Edwards Lifesciences’ Adjusted Sales Grew 9.3%; Adjusted EPS Surged 30%
finance.yahoo.com - May 8 at 9:24 AM
Edwards Lifesciences (EW) Upgraded to "Buy" at ValuEngineEdwards Lifesciences (EW) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - May 7 at 11:10 PM
Edwards Lifesciences (EW) VP Sells $501,334.00 in StockEdwards Lifesciences (EW) VP Sells $501,334.00 in Stock
www.americanbankingnews.com - May 7 at 10:26 PM
Edwards Lifesciences (EW) CEO Michael A. Mussallem Sells 32,800 SharesEdwards Lifesciences (EW) CEO Michael A. Mussallem Sells 32,800 Shares
www.americanbankingnews.com - May 7 at 10:26 PM
Market Trends Toward New Normal in Anadarko Petroleum, Edwards Lifesciences ...Market Trends Toward New Normal in Anadarko Petroleum, Edwards Lifesciences ...
globenewswire.com - May 7 at 9:58 AM
Market Trends Toward New Normal in Anadarko Petroleum, Edwards Lifesciences, American Eagle Outfitters, Express, Norfolk Southern, and Investors Real Estate Trust — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Anadarko Petroleum, Edwards Lifesciences, American Eagle Outfitters, Express, Norfolk Southern, and Investors Real Estate Trust — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - May 7 at 9:58 AM
Edwards Lifesciences (EW) ASR Announcement is a Buy Signal - Evercore ISIEdwards Lifesciences (EW) ASR Announcement is a Buy Signal - Evercore ISI
www.streetinsider.com - May 5 at 9:32 AM
Head-To-Head Analysis: ConforMIS (CFMS) versus Edwards Lifesciences (EW)Head-To-Head Analysis: ConforMIS (CFMS) versus Edwards Lifesciences (EW)
www.americanbankingnews.com - May 5 at 3:13 AM
Reviewing Edwards Lifesciences (EW) and Invacare (IVC)Reviewing Edwards Lifesciences (EW) and Invacare (IVC)
www.americanbankingnews.com - May 2 at 7:28 PM
Insider Selling: Edwards Lifesciences (EW) CEO Sells 32,800 Shares of StockInsider Selling: Edwards Lifesciences (EW) CEO Sells 32,800 Shares of Stock
www.americanbankingnews.com - May 2 at 7:22 PM
Edwards launches $400M accelerated share buyback programEdwards launches $400M accelerated share buyback program
seekingalpha.com - May 1 at 9:19 AM
Edwards Lifesciences Enters Into Accelerated Share Repurchase AgreementEdwards Lifesciences Enters Into Accelerated Share Repurchase Agreement
finance.yahoo.com - May 1 at 9:19 AM
Edwards Granted CE Mark For First Transcatheter Tricuspid TherapyEdwards Granted CE Mark For First Transcatheter Tricuspid Therapy
finance.yahoo.com - April 30 at 4:33 PM
Edwards Lifesciences (EW) Forecasted to Earn Q3 2018 Earnings of $1.07 Per ShareEdwards Lifesciences (EW) Forecasted to Earn Q3 2018 Earnings of $1.07 Per Share
www.americanbankingnews.com - April 30 at 2:48 AM
Edwards Lifesciences (EW) to Post Q3 2018 Earnings of $1.04 Per Share, Jefferies Group ForecastsEdwards Lifesciences (EW) to Post Q3 2018 Earnings of $1.04 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - April 27 at 8:50 AM
Q2 2018 Earnings Estimate for Edwards Lifesciences (EW) Issued By William BlairQ2 2018 Earnings Estimate for Edwards Lifesciences (EW) Issued By William Blair
www.americanbankingnews.com - April 27 at 7:44 AM
Q2 2018 EPS Estimates for Edwards Lifesciences (EW) Lowered by AnalystQ2 2018 EPS Estimates for Edwards Lifesciences (EW) Lowered by Analyst
www.americanbankingnews.com - April 27 at 7:44 AM
 Analysts Expect Edwards Lifesciences (EW) Will Post Quarterly Sales of $975.26 Million Analysts Expect Edwards Lifesciences (EW) Will Post Quarterly Sales of $975.26 Million
www.americanbankingnews.com - April 27 at 1:44 AM
Edwards Lifesciences (EW) Expected to Earn FY2018 Earnings of $4.62 Per ShareEdwards Lifesciences (EW) Expected to Earn FY2018 Earnings of $4.62 Per Share
www.americanbankingnews.com - April 26 at 10:24 AM
Q3 2018 EPS Estimates for Edwards Lifesciences Raised by William Blair (EW)Q3 2018 EPS Estimates for Edwards Lifesciences Raised by William Blair (EW)
www.americanbankingnews.com - April 26 at 9:44 AM
Edited Transcript of EW earnings conference call or presentation 24-Apr-18 9:00pm GMTEdited Transcript of EW earnings conference call or presentation 24-Apr-18 9:00pm GMT
finance.yahoo.com - April 26 at 9:20 AM
Stock Traders Purchase Large Volume of Put Options on Edwards Lifesciences (EW)Stock Traders Purchase Large Volume of Put Options on Edwards Lifesciences (EW)
www.americanbankingnews.com - April 26 at 6:46 AM
Zacks: Analysts Anticipate Edwards Lifesciences (EW) Will Post Earnings of $1.17 Per ShareZacks: Analysts Anticipate Edwards Lifesciences (EW) Will Post Earnings of $1.17 Per Share
www.americanbankingnews.com - April 25 at 11:10 PM
Edwards Lifesciences: 1Q Earnings SnapshotEdwards Lifesciences: 1Q Earnings Snapshot
www.cnbc.com - April 25 at 4:34 PM
Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues MissEdwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss
finance.yahoo.com - April 25 at 4:34 PM

SEC Filings

Edwards Lifesciences (NYSE:EW) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Edwards Lifesciences (NYSE:EW) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Edwards Lifesciences (NYSE EW) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.